Repligen RGEN
NASDAQ RGEN
$182.47 +2.46 (+1.37%)
As of: Oct 22, 2026 · 11:05 AM EDT

Repligen (RGEN) Liabilities and Shareholders Equity (2011 - 2026)

Updated

Repligen's Liabilities and Shareholders Equity came in at $2.95 billion for Q2 2026, up 1.7% from $2.9 billion a year earlier and up 0.7% from the prior quarter.

Analysis

Repligen (RGEN) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends

Going back to Q4 2011, Repligen's Liabilities and Shareholders Equity data covers 58 quarters.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 9.2% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $2.83 billion in FY2024 (-0.1%), $2.83 billion in FY2023 (+11.8%), $2.53 billion in FY2022 (+7.3%) and $2.36 billion in FY2021 (+23.9%).
  • The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2011.
  • Year-over-year, Liabilities and Shareholders Equity has increased for five consecutive quarters, with growth averaging 3.2% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q3 2021 (growth of 51.8%), and the weakest in Q1 2025 (a decline of 0.1%).
  • Business Quant data shows RGEN's Liabilities and Shareholders Equity at $2.93 billion (Q1 2026), $2.95 billion (Q4 2025) and $2.92 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 254.81 Bn 233.84 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 175.33 Bn 145.76 Bn 7.27 Bn 109.22 Bn
3 Danaher 164.57 Bn 148.38 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 155.98 Bn 135.40 Bn 1.96 Bn 20.88 Bn
5 Medtronic 121.89 Bn 87.15 Bn 6.34 Bn 93.31 Bn
6 Stryker 117.20 Bn 103.32 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 66.51 Bn 61.28 Bn 3.85 Bn 45.22 Bn
8 Becton Dickinson 54.39 Bn 51.54 Bn 2.32 Bn 50.73 Bn
9 Edwards Lifesciences 51.62 Bn 35.62 Bn 1.35 Bn 13.87 Bn
10 Repligen 10.27 Bn 7.15 Bn 110.04 Mn 2.95 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.95 Bn
Mar 31, 2026 2.93 Bn
Dec 31, 2025 2.95 Bn
Sep 30, 2025 2.92 Bn
Jun 30, 2025 2.90 Bn
Mar 31, 2025 2.85 Bn
Dec 31, 2024 2.83 Bn
Sep 30, 2024 2.83 Bn
Jun 30, 2024 2.87 Bn
Mar 31, 2024 2.85 Bn
Dec 31, 2023 2.83 Bn
Sep 30, 2023 2.52 Bn
Jun 30, 2023 2.56 Bn
Mar 31, 2023 2.55 Bn
Dec 31, 2022 2.53 Bn
Sep 30, 2022 2.46 Bn
Jun 30, 2022 2.44 Bn
Mar 31, 2022 2.38 Bn
Dec 31, 2021 2.36 Bn
Sep 30, 2021 2.24 Bn
API Access

Repligen Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RGEN&period=max&api_key=YOUR_API_KEY